BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30580275)

  • 1. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
    Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
    BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
    Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
    Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial consequences of receiving false-positive colorectal cancer screening results: a qualitative study.
    Toft EL; Kaae SE; Malmqvist J; Brodersen J
    Scand J Prim Health Care; 2019 Jun; 37(2):145-154. PubMed ID: 31079520
    [No Abstract]   [Full Text] [Related]  

  • 7. Health literacy levels and views about being invited to a colorectal cancer screening program.
    Wangmar J; Jervaeus A; Fritzell K; Wångdahl J; Hultcrantz R; Wengström Y
    Acta Oncol; 2018 Jun; 57(6):743-749. PubMed ID: 29308944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial.
    de Wijkerslooth TR; de Haan MC; Stoop EM; Bossuyt PM; Thomeer M; Essink-Bot ML; van Leerdam ME; Fockens P; Kuipers EJ; Stoker J; Dekker E
    Gut; 2012 Nov; 61(11):1552-9. PubMed ID: 22198714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
    Dodd N; Mansfield E; Carey M; Oldmeadow C
    Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does theory of planned behaviour play a role in predicting uptake of colorectal cancer screening? A cross-sectional study in Hong Kong.
    Huang J; Wang J; Pang TW; Chan MK; Leung S; Chen X; Leung C; Zheng ZJ; Wong MC
    BMJ Open; 2020 Aug; 10(8):e037619. PubMed ID: 32764087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different information needs-The major reasons for calling the helpline when invited to colorectal cancer screening.
    Fritzell K; Kottorp A; Jervaeus A
    Health Expect; 2022 Aug; 25(4):1548-1554. PubMed ID: 35393757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-making about participation in colorectal cancer screening in Sweden: Autonomous, value-dependent but uninformed?
    Wangmar J; Wengström Y; Jervaeus A; Hultcrantz R; Fritzell K
    Patient Educ Couns; 2021 Apr; 104(4):919-926. PubMed ID: 32980202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of people's values and preferences for colorectal cancer screening participation.
    Fritzell K; Stake Nilsson K; Jervaeus A; Hultcrantz R; Wengström Y
    Eur J Public Health; 2017 Dec; 27(6):1079-1084. PubMed ID: 28160484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT).
    Lim TZ; Lau J; Wong GJ; Tan LY; Chang YJ; Natarajan K; Yi H; Wong ML; Tan KK
    Cancer Med; 2021 Nov; 10(21):7735-7746. PubMed ID: 34519182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.